China Universal Asset Management Company’s Enliven Therapeutics ELVN Stock Holding History

China Universal Asset Management Company’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492K	Sell	9,693 -839	-8%	-$35.6K	0.03%	267
2026 Q1	$413K	Buy	10,532 +861	+9%	+$23.9K	0.03%	275
2025 Q4	$149K	Sell	9,671 -712	-7%	-$14.2K	0.01%	376
2025 Q3	$213K	Buy	10,383 +528	+5%	+$10.6K	0.02%	332
2025 Q2	$198K	Buy	9,855 +55	+0.6%	+$1.04K	0.02%	313
2025 Q1	$193K	Sell	9,800 -560	-5%	-$12.1K	0.02%	315
2024 Q4	$233K	Buy	10,360 +1,275	+14%	+$33.1K	0.02%	316
2024 Q3	$232K	Buy	9,085 +3,559	+64%	+$82.4K	0.03%	288
2024 Q2	$129K	Sell	5,526 -2,426	-31%	-$51.1K	0.02%	282
2024 Q1	$140K	Buy	7,952 +3,189	+67%	+$48.9K	0.02%	336
2023 Q4	$65.9K	Buy	+4,763	New	+$58.3K	0.01%	336

Other funds holding ELVN

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

China Universal Asset Management Company's ELVN Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Enliven Therapeutics (ELVN) stake by 8% in Q2 2026, selling an estimated $35.6K and leaving 9,693 shares worth $492K. The position accounts for 0.03% of the portfolio, ranked #267.

China Universal Asset Management Company first reported a position in ELVN in Q4 2023 and has held it in 11 quarters since. 21 funds tracked by Wall St. Rank hold ELVN as of Q2 2026.

China Universal Asset Management Company held 9,693 shares of Enliven Therapeutics worth $492K as of Q2 2026.
China Universal Asset Management Company sold 839 Enliven Therapeutics shares in Q2 2026, an estimated $35.6K.
Enliven Therapeutics made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #267 holding.
China Universal Asset Management Company first reported a position in Enliven Therapeutics in Q4 2023 and has held it in 11 quarters since.
21 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.